HIV entry in macrophages is dependent on intact lipid rafts

Virology

Volumn 386, Issue 1, 2009, Pages 192-202

  Carter, Gemma C ^a   Bernstone, Laura ^a   Sangani, Dhaval ^a   Bee, Jessica Wynter ^a   Harder, Thomas ^a   James, William ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cholesterol; Entry; HIV; Lipid rafts; Macrophages

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CD71 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CHOLESTEROL; FILIPIN; FLOTILLIN 1; MEMBRANE LIPID; METHYL BETA CYCLODEXTRIN; MEVINOLIN; NYSTATIN; VIRUS RECEPTOR;

ARTICLE; CELL MEMBRANE RESISTANCE; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LIPID RAFT; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS TRANSCRIPTION;

ANTIMETABOLITES; BETA-CYCLODEXTRINS; CELLS, CULTURED; FILIPIN; HIV-1; HUMANS; LOVASTATIN; MACROPHAGES; MEMBRANE MICRODOMAINS; NYSTATIN; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 61649098778     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.12.031     Document Type: Article

References (64)

1. Aloia R.C., Jensen F.C., Curtain C.C., Mobley P.W., and Gordon L.M. Lipid composition and fluidity of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 85 3 (1988) 900-904
2. Aloia R.C., Tian H., and Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 90 11 (1993) 5181-5185
3. Anderson H.A., Chen Y., and Norkin L.C. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7 11 (1996) 1825-1834
4. Bender F.C., Whitbeck J.C., Ponce de Leon M., Lou H., Eisenberg R.J., and Cohen G.H. Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J. Virol. 77 17 (2003) 9542-9552
5. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., and Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U. S. A. 103 8 (2006) 2641-2646
6. Brugger B., Krautkramer E., Tibroni N., Munte C.E., Rauch S., Leibrecht I., Glass B., Breuer S., Geyer M., Krausslich H.G., Kalbitzer H.R., Wieland F.T., and Fackler O.T. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 4 (2007) 70
7. Bukrinsky M., and Sviridov D. Human immunodeficiency virus infection and macrophage cholesterol metabolism. J. Leukoc. Biol. 80 5 (2006) 1044-1051
8. Butler S.L., Hansen M.S., and Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7 5 (2001) 631-634
9. Campbell S.M., Crowe S.M., and Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 16 17 (2002) 2253-2261
10. Campbell S., Gaus K., Bittman R., Jessup W., Crowe S., and Mak J. The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J. Virol. 78 19 (2004) 10556-10565
11. Cardaba C.M., Kerr J.S., and Mueller A. CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity. Cell. Signal. 20 9 (2008) 1687-1694
12. Castrillo A., Joseph S.B., Vaidya S.A., Haberland M., Fogelman A.M., Cheng G., and Tontonoz P. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12 4 (2003) 805-816
13. Chan R., Uchil P.D., Jin J., Shui G., Ott D.E., Mothes W., and Wenk M.R. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82 22 (2008) 11228-11238
14. Chung C.S., Huang C.Y., and Chang W. Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J. Virol. 79 3 (2005) 1623-1634
15. Cohen C., Forzan M., Sproat B., Pantophlet R., McGowan I., Burton D., and James W. An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site. Virology 381 1 (2008) 46-54
16. Collman R., Godfrey B., Cutilli J., Rhodes A., Hassan N.F., Sweet R., Douglas S.D., Friedman H., Nathanson N., and Gonzalez-Scarano F. Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J. Virol. 64 9 (1990) 4468-4476
17. Del Real G., Jimenez-Baranda S., Lacalle R.A., Mira E., Lucas P., Gomez-Mouton C., Carrera A.C., Martinez A.C., and Manes S. Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J. Exp. Med. 196 3 (2002) 293-301
18. del Real G., Jimenez-Baranda S., Mira E., Lacalle R.A., Lucas P., Gomez-Mouton C., Alegret M., Pena J.M., Rodriguez-Zapata M., Alvarez-Mon M., Martinez A.C., and Manes S. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200 4 (2004) 541-547
19. Funk A., Mhamdi M., Hohenberg H., Heeren J., Reimer R., Lambert C., Prange R., and Sirma H. Duck hepatitis B virus requires cholesterol for endosomal escape during virus entry. J. Virol. 82 21 (2008) 10532-10542
20. Gartner S., Markovits P., Markovitz D.M., Betts R.F., and Popovic M. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256 17 (1986) 2365-2371
21. Giguere J.F., and Tremblay M.J. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J. Virol. 78 21 (2004) 12062-12065
22. Guyader M., Kiyokawa E., Abrami L., Turelli P., and Trono D. Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J. Virol. 76 20 (2002) 10356-10364
23. Harder T., and Kuhn M. Selective accumulation of raft-associated membrane protein LAT in T cell receptor signaling assemblies. J. Cell Biol. 151 2 (2000) 199-208
24. Harmon B., and Ratner L. Induction of the G{alpha}q signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J. Virol. 82 18 (2008) 9191-9205
25. Hogle J.M. Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu. Rev. Microbiol. 56 (2002) 677-702
26. Ilangumaran S., and Hoessli D.C. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem. J. 335 Pt 2 (1998) 433-440
27. Kazazi F., Mathijs J.M., Foley P., and Cunningham A.L. Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J. Gen. Virol. 70 Pt 10 (1989) 2661-2672
28. Kozak S.L., Heard J.M., and Kabat D. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76 4 (2002) 1802-1815
29. Lee B., Sharron M., Montaner L.J., Weissman D., and Doms R.W. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 96 9 (1999) 5215-5220
30. Li G.M., Li Y.G., Yamate M., Li S.M., and Ikuta K. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 9 1 (2007) 96-102
31. Liao Z., Cimakasky L.M., Hampton R., Nguyen D.H., and Hildreth J.E. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retrovir. 17 11 (2001) 1009-1019
32. Liao Z., Graham D.R., and Hildreth J.E. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res. Hum. Retrovir. 19 8 (2003) 675-687
33. Liu N.Q., Lossinsky A.S., Popik W., Li X., Gujuluva C., Kriederman B., Roberts J., Pushkarsky T., Bukrinsky M., Witte M., Weinand M., and Fiala M. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol. 76 13 (2002) 6689-6700
34. Lu X., and Silver J. Ecotropic murine leukemia virus receptor is physically associated with caveolin and membrane rafts. Virology 276 2 (2000) 251-258
35. Manes S., Mira E., Gomez-Mouton C., Lacalle R.A., Keller P., Labrador J.P., and Martinez A.C. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 18 22 (1999) 6211-6220
36. Manes S., del Real G., Lacalle R.A., Lucas P., Gomez-Mouton C., Sanchez-Palomino S., Delgado R., Alcami J., Mira E., and Martinez A.C. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1 2 (2000) 190-196
37. Marechal V., Prevost M.C., Petit C., Perret E., Heard J.M., and Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75 22 (2001) 11166-11177
38. Marjomaki V., Pietiainen V., Matilainen H., Upla P., Ivaska J., Nissinen L., Reunanen H., Huttunen P., Hyypia T., and Heino J. Internalization of echovirus 1 in caveolae. J. Virol. 76 4 (2002) 1856-1865
39. Marsh M., and Helenius A. Virus entry: open sesame. Cell 124 4 (2006) 729-740
40. Mujawar Z., Rose H., Morrow M.P., Pushkarsky T., Dubrovsky L., Mukhamedova N., Fu Y., Dart A., Orenstein J.M., Bobryshev Y.V., Bukrinsky M., and Sviridov D. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 4 11 (2006) e365
41. Nabatov A.A., Pollakis G., Linnemann T., Paxton W.A., and de Baar M.P. Statins disrupt CCR5 and RANTES expression levels in CD4+ T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1. PLoS ONE 2 5 (2007) e470
42. Nguyen D.H., and Taub D. Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. Blood 99 12 (2002) 4298-4306
43. Nguyen D.H., and Taub D. CXCR4 function requires membrane cholesterol: implications for HIV infection. J. Immunol. 168 8 (2002) 4121-4126
44. Nguyen D.H., Giri B., Collins G., and Taub D.D. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp. Cell Res. 304 2 (2005) 559-569
45. Pelchen-Matthews A., da Silva R.P., Bijlmakers M.J., Signoret N., Gordon S., and Marsh M. Lack of p56lck expression correlates with CD4 endocytosis in primary lymphoid and myeloid cells. Eur. J. Immunol. 28 11 (1998) 3639-3647
46. Percherancier Y., Lagane B., Planchenault T., Staropoli I., Altmeyer R., Virelizier J.L., Arenzana-Seisdedos F., Hoessli D.C., and Bachelerie F. HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J. Biol. Chem. 278 5 (2003) 3153-3161
47. Pietiainen V., Marjomaki V., Upla P., Pelkmans L., Helenius A., and Hyypia T. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol. Biol. Cell 15 11 (2004) 4911-4925
48. Popik W., and Alce T.M. CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J. Biol. Chem. 279 1 (2004) 704-712
49. Popik W., Alce T.M., and Au W.C. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J. Virol. 76 10 (2002) 4709-4722
50. Risselada J., and Marrink S. The molecular face of lipid rafts in model membranes. Proc. Natl. Acad. Sci. 105 45 (2008) 17367-17372
51. Saphire A.C., Bobardt M.D., Zhang Z., David G., and Gallay P.A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75 19 (2001) 9187-9200
52. Schneider B., Schueller C., Utermoehlen O., and Haas A. Lipid microdomain-dependent macropinocytosis determines compartmentation of Afipia felis. Traffic 8 3 (2007) 226-240
53. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 6633 (1997) 569-572
54. Singer I.I., Scott S., Kawka D.W., Chin J., Daugherty B.L., DeMartino J.A., DiSalvo J., Gould S.L., Lineberger J.E., Malkowitz L., Miller M.D., Mitnaul L., Siciliano S.J., Staruch M.J., Williams H.R., Zweerink H.J., and Springer M.S. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J. Virol. 75 8 (2001) 3779-3790
55. Smith A.E., and Helenius A. How viruses enter animal cells. Science 304 5668 (2004) 237-242
56. Steffens C.M., and Hope T.J. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J. Virol. 78 17 (2004) 9573-9578
57. Sun X., and Whittaker G.R. Role for influenza virus envelope cholesterol in virus entry and infection. J. Virol. 77 23 (2003) 12543-12551
58. Tang H., Kawabata A., Takemoto M., Yamanishi K., and Mori Y. Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology 378 2 (2008) 265-271
59. Umashankar M., Sanchez-San Martin C., Liao M., Reilly B., Guo A., Taylor G., and Kielian M. Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J. Virol. 82 18 (2008) 9245-9253
60. van 't Wout A.B., Swain J.V., Schindler M., Rao U., Pathmajeyan M.S., Mullins J.I., and Kirchhoff F. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J. Virol. 79 15 (2005) 10053-10058
61. Viard M., Parolini I., Sargiacomo M., Fecchi K., Ramoni C., Ablan S., Ruscetti F.W., Wang J.M., and Blumenthal R. Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J. Virol. 76 22 (2002) 11584-11595
62. Watarai M., Makino S., Fujii Y., Okamoto K., and Shirahata T. Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication. Cell Microbiol 4 6 (2002) 341-355
63. Wilflingseder D., and Stoiber H. Float on: lipid rafts in the lifecycle of HIV. Front. Biosci. 12 (2007) 2124-2135
64. Zheng Y.H., Plemenitas A., Fielding C.J., and Peterlin B.M. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc. Natl. Acad. Sci. U. S. A. 100 14 (2003) 8460-8465